Drawing for HEPOID

USPTO serial 90094968

HEPOID

Reviewed by CopyMark Law Group

Reg. 6610706Status 700Renewal
Filing date
Status date
Registration date
Jan 11, 2022
Examiner
FOSS, KATHERINE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEPOID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Peter Spies

R. Peter Spies DINEFF TRADEMARK LAW LIMITED160 N. WACKER DRIVECHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Products made from or derived from hepatic cells for medical researchACTIVE—
005Pharmaceutical and veterinary preparations, namely, preparations based on hepatic cell models, preparations in the field of hepatotoxicity and liver disease, preparations for in vivo and in vitro tests, in particular for tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; hygienic preparations for medicine based on hepatic cell models; chemical preparations for medical or pharmaceutical purposes, namely, preparations for testing or treating hepatotoxicity/hepatic metabolism and associated mechanisms or liver diseases; Cellular preparations for medicine; products made from or derived from cells for medical research; Product based on or derived from hepatic cells, for the performance of toxicity tests for medical purposesACTIVE—
009Measuring instruments and apparatus for diagnosis, other than for medical use, namely, scientific apparatus and instruments for drug discovery screening; data processing equipment and apparatus; recorded software programs for use in drug discovery screening; apparatus computer equipment apparatus, namely, computer peripheral devices and computers, for medical research and diagnosis and for drug discovery screening; recorded software programs for drug discovery screening; diagnostic devices not for medical use, namely, diagnostic apparatus for conducting tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; devices for non-medical metabolism testingACTIVE—
010Surgical apparatus and instruments; medical apparatus and instruments for the diagnostic and treatment of liver disease; medical apparatus and instruments for testing metabolism; medical apparatus and instruments using hepatic cell models for disease diagnosis or treatment; medical apparatus and instruments for in vivo and in vitro tests using hepatic cell models; veterinary apparatus and instruments using hepatic cell models for disease diagnosis or treatment; diagnostic apparatus for medical purposes for conducting test using hepatic cell models; apparatus for use in medical analysis, namely, for measuring liver disease and testing metabolismACTIVE—
042Evaluations provided by engineers, namely, drug discovery screening; estimates provided by engineers, namely, estimations regarding drug discovery screening; scientific research provided by engineers; technological research in the field of hepatic cells and drug discovery screening provided by engineers; scientific and technological services in the medical and diagnostic field, namely, providing medical testing services and information in the field of hepatic cells; scientific research in the field of diagnostics or for medical purposes; electronic storage of medical records; design, development, maintenance and hosting of databases of medical images and patient data; computer programming in the field of diagnostics or medicine; design and development of medical diagnostic apparatus and equipment; design and development of software for use in medical technology in the field of diagnostics; computer aided diagnostic services in the field of hepatotoxicity and liver disease, computer aided diagnostic services in the field of in vivo and in vitro tests; providing scientific information in the medical field; temporary online provision of non-downloadable operating software allowing access to a computer network; software as a service; services featuring software in the field of diagnostics or medicine for processing and displaying data resulting from drug discovery screening; research and development of new products for others; technical project studies, namely, conducting feasibility studies in the field of drug discovery screening; design and development of computer and software in the medical and diagnostic field; computer software consultancy services in the field of diagnostics for medical purposes; medical research; design and development, installation, maintenance, updating or rental of software; programming for computers; computer technology consultancy; conversion of data and computer programs other than physical conversion; conversion of documents from a physical medium to an electronic medium; scientific research for medical purposes. services relating to cellular products for the medical field, namely, preparing in vitro tests, in particular tests for assessing hepatotoxicity/hepatic metabolism and associated mechanisms; services relating to cellular products for the medical field, namely, drug discovery screening; toxicology services, namely, analytical services related to cellular products to support for toxicity studiesACTIVE—
044Medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 23, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 23, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 23, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 27, 2021DOCKASSIGNED TO EXAMINER—
Jul 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2021ALIEASSIGNED TO LIE—
Apr 28, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 28, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2020DOCKASSIGNED TO EXAMINER—
Sep 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance